Regen BioPharma Inc (RGBP)
0.70
-0.04
(-5.41%)
USD |
OTCM |
Apr 26, 16:00
Regen BioPharma Market Cap: 2.625M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 2.625M |
| April 25, 2024 | 2.775M |
| April 24, 2024 | 2.775M |
| April 23, 2024 | 2.625M |
| April 22, 2024 | 2.625M |
| April 19, 2024 | 2.550M |
| April 18, 2024 | 2.625M |
| April 17, 2024 | 2.130M |
| April 16, 2024 | 2.152M |
| April 15, 2024 | 2.438M |
| April 12, 2024 | 2.625M |
| April 11, 2024 | 2.175M |
| April 10, 2024 | 2.380M |
| April 09, 2024 | 2.288M |
| April 08, 2024 | 2.438M |
| April 05, 2024 | 2.700M |
| April 04, 2024 | 3.000M |
| April 03, 2024 | 2.997M |
| April 02, 2024 | 2.813M |
| April 01, 2024 | 2.400M |
| March 28, 2024 | 2.813M |
| March 27, 2024 | 2.775M |
| March 26, 2024 | 2.813M |
| March 25, 2024 | 2.734M |
| March 22, 2024 | 2.932M |
| Date | Value |
|---|---|
| March 21, 2024 | 2.813M |
| March 20, 2024 | 2.926M |
| March 19, 2024 | 2.884M |
| March 18, 2024 | 2.700M |
| March 15, 2024 | 2.850M |
| March 14, 2024 | 2.888M |
| March 13, 2024 | 2.850M |
| March 12, 2024 | 2.939M |
| March 11, 2024 | 2.812M |
| March 08, 2024 | 3.105M |
| March 07, 2024 | 2.952M |
| March 06, 2024 | 3.300M |
| March 05, 2024 | 3.226M |
| March 04, 2024 | 2.956M |
| March 01, 2024 | 3.263M |
| February 29, 2024 | 3.103M |
| February 28, 2024 | 3.131M |
| February 27, 2024 | 3.224M |
| February 26, 2024 | 3.394M |
| February 23, 2024 | 3.076M |
| February 22, 2024 | 3.188M |
| February 21, 2024 | 3.338M |
| February 20, 2024 | 3.413M |
| February 16, 2024 | 3.376M |
| February 15, 2024 | 3.150M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.0014M
Minimum
Mar 12 2020
263.29M
Maximum
Aug 27 2021
21.83M
Average
5.748M
Median
Apr 28 2023
Market Cap Benchmarks
| CervoMed Inc | 146.98M |
| GlucoTrack Inc | 12.18M |
| AIM ImmunoTech Inc | 21.37M |
| Protalix BioTherapeutics Inc | 84.01M |
| Armata Pharmaceuticals Inc | 99.76M |
Market Cap Related Metrics
| PS Ratio | 11.06 |
| Price | 0.70 |
| Earnings Yield | -37.14% |